Akari Therapeutics is an oncology biotechnology company developing next-generation antibody drug conjugates (ADCs) with a unique payload, PH1, which targets RNA splicing. Utilizing its innovative ADC ...

Plenary Presentation Highlights How Aligning Inflammatory Biomarker Enrichment with Mechanism of Action Offers a Blueprint for Success in Alzheimer’s Drug Development Boca Raton, FL, March 19, 2026 ...

Marshall County residents, government officials, business owners, and all interested are invited to a presentation from Jim Engle, Iowa Downtown Resource Center Director and Jim Thompson, Downtown ...

None ...

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will present new ...

Hello, and welcome to the Life Science Investor Forum . On behalf of OTC Markets and our co-host, Zacks Small Cap Research , we are very pleased you have joined us. The next presentation of the day is ...

A look back at the can't-miss croissant on the sports conference circuit, and why Bradford City and Wigan Athletic might be ...

Technology transformation in casualty claims does not begin with artificial intelligence. For Joel Raedeke (pictured), US ...

Referral software companies are another example of businesses that are unlikely to be heavily disrupted by AI. Their products usually function as execution tools for their customers rather than ...

A portable workstation and a lifetime productivity suite for $260? Entrepreneurs, pay attention.

Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing rapid near-patient tests for critical care conditions, today announced that an abstract ...

Video game fans are responding with criticism and comedy to Nvidia's latest version of its AI technology that boost performance and graphics. DLSS, Nvidia's image enhancement technology was ...